Devyser wins tender in Italy worth approximately SEK 5.7 million – doubling test volumes compared with previous agreement
Devyser Diagnostics AB, through its Italian subsidiary, has been awarded a renewed tender by...
News | July 3, 2018
Devyser is pleased to announce the publication of a new whitepaper Familial Hypercholesterolemia: Genetic Diagnosis and Cascade Testing Using NGS
The 6th in our Expert Review series, this paper is co-authored by Peter Benedek and Kristina Duvefelt, of Karolinska University Hospital, Stockholm.
The paper is a guide to conducting testing using NGS, and the benefits of implementing cascade screening for FH, which is a dominant yet highly underdiagnosed heriditary disorder. Affected individuals are affected by high levels of LDL-cholesterol, and early onset cardiovascular disease and death.
Devyser Diagnostics AB, through its Italian subsidiary, has been awarded a renewed tender by...
Read More
Devyser announced that One Lambda™ Devyser Accept cfDNA, its test for monitoring kidney transplant...
Read More
Devyser, a global leader in advanced molecular diagnostics, today announced the first commercial...
Read More
One Lambda™ Devyser Chimerism Plus is a next generation solution for chimerism analysis following...
Read More